» Articles » PMID: 22220260

Causes of Adult Splanchnic Vein Thrombosis in the Mediterranean Area

Overview
Date 2012 Jan 6
PMID 22220260
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The term splanchnic vein thrombosis encompasses Budd-Chiari syndrome (BCS), extrahepatic portal vein obstruction (EHPVO), and mesenteric vein thrombosis.Risk factors can be local or systemic. A local precipitating factor is rare in BCS, while it is common in patients with portal vein thrombosis. Chronic myeloproliferative neoplasms (MPN) are the leading systemic cause of splanchnic vein thrombosis, and are diagnosed in half BCS patients and one-third of EHPVO patients; the somatic mutation JAK2 V617F is detectable in a large majority of patients with overt MPN, and up to 40% of patients without overt MPN. Inherited thrombophilia is present in at least one-third of patients, and the factor V Leiden or the prothrombin G20210A mutations are the most common mutations found in BCS or EHPVO patients, respectively. Multiple factors are present in approximately one-third of patients with BCS and two- thirds of patients with portal vein thrombosis.In a few patient series from the Southern Mediterranean area the high prevalence of MPN and thrombophilia as underlying cause of BCS is confirmed, although the data should be considered preliminary. Peculiar risk factors present in the area are Behçet's disease and hydatidosis; moreover, membraneous webs, typically found in Asian patients, are present in a significant portion of cases.

Citing Articles

Is there a gender effect in polycythemia vera?.

Palandri F, Mora B, Gangat N, Catani L Ann Hematol. 2020; 100(1):11-25.

PMID: 33006021 PMC: 7782364. DOI: 10.1007/s00277-020-04287-w.


Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease.

How J, Zhou A, Oh S Ther Adv Hematol. 2017; 8(3):107-118.

PMID: 28246554 PMC: 5305004. DOI: 10.1177/2040620716680333.


PAI-1 4G-4G, MTHFR 677TT, V Leiden 506Q, and Prothrombin 20210A in Splanchnic Vein Thrombosis: Analysis of Individual Patient Data From Three Prospective Studies.

Pasta L, Pasta F, DAmico M J Clin Exp Hepatol. 2016; 6(1):10-4.

PMID: 27194890 PMC: 4862015. DOI: 10.1016/j.jceh.2015.11.002.


Massive Esophageal Variceal Bleeding as a Rare Complication of Sickle Cell Anemia.

Malamood M, Bernstein G, Malik Z, Mathur M ACG Case Rep J. 2016; 3(2):92-4.

PMID: 26958556 PMC: 4748192. DOI: 10.14309/crj.2016.10.


Imaging Diagnosis of Splanchnic Venous Thrombosis.

Rajesh S, Mukund A, Arora A Gastroenterol Res Pract. 2015; 2015:101029.

PMID: 26600801 PMC: 4620257. DOI: 10.1155/2015/101029.


References
1.
Kumar S, Sarr M, Kamath P . Mesenteric venous thrombosis. N Engl J Med. 2002; 345(23):1683-8. DOI: 10.1056/NEJMra010076. View

2.
Dahabreh I, Zoi K, Giannouli S, Zoi C, Loukopoulos D, Voulgarelis M . Is JAK2 V617F mutation more than a diagnostic index? A meta-analysis of clinical outcomes in essential thrombocythemia. Leuk Res. 2008; 33(1):67-73. DOI: 10.1016/j.leukres.2008.06.006. View

3.
Primignani M, Barosi G, Bergamaschi G, Gianelli U, Fabris F, Reati R . Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology. 2006; 44(6):1528-34. DOI: 10.1002/hep.21435. View

4.
Valla D, Le M, Poynard T, Zucman N, RUEFF B, Benhamou J . Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A case-control study. Gastroenterology. 1986; 90(4):807-11. DOI: 10.1016/0016-5085(86)90855-3. View

5.
Fiorini A, Chiusolo P, Rossi E, Za T, De Ritis D, Ciminello A . Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms. Am J Hematol. 2008; 84(2):126-7. DOI: 10.1002/ajh.21335. View